Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer
نویسندگان
چکیده
منابع مشابه
cytotoxic t lymphocyte associated molecule -4 (ctla-4) gene polymorphisms in ovarian cancer patients
background: ovarian cancer is a relatively common cancer among postmenopausal women. nowadays, there is controversy about immunotherapy of ovarian cancer patients with interleukins such as interferon to reach better out come in prognosis of patients under chemotherapy. ctla-4 is a gene, which has an important role in homeostasis and regulation of immune response. inhibitory nature of ctla-4 is ...
متن کاملAdoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging.
We have shown previously that T cells, tagged with biotinylated anti-CD3 antibody fragments, can exert avidin-dependent cytolytic activity on suitably biotinylated tumor cells in vitro. In this study, we demonstrate that avidin-driven CTL-tumor bridging in vivo leads to growth inhibition of murine tumors WEHI-164 fibrosarcoma and RMA lymphoma. The biodistribution of biotin-tagged 111In-labeled ...
متن کاملChitosan thermogels for local T lymphocyte delivery for cancer immunotherapy
Background The success of systemic adoptive T cell transfer lies in the capacity of the antigen-experienced cytotoxic T lymphocytes to access and persist within the tumour microenvironment. The mimicking of tertiary lymphoid structures that promote a protective immune response against cancer can be achieved using an injectable biocompatible matrix that releases anti-tumour, proliferating T lymp...
متن کاملT lymphocyte engineering with cytokine nanogels for enhanced cancer immunotherapy
Background Adoptive cell transfer (ACT) with autologous tumorreactive T cells is a promising strategy in cancer immunotherapy, but treatment of solid tumors is limited by the rapid decline in function of the transplanted T cells. In order to maintain high numbers of viable antigen-specific cytotoxic T cells in tumors, co-administration of supporting immunostimulant agents together with transfer...
متن کاملActivated cytotoxic T-lymphocyte immunotherapy is effective for advanced oral and maxillofacial cancers.
Conventional cancer treatments are surgery, radiotherapy, and chemotherapy, but treatment efficiency is insufficient and cancer recurrence is common. Immunotherapy has been added as an important cancer treatment component, but no reports on its efficacy in oral and maxillofacial cancers exist. We evaluated the clinical efficacy of adoptive immunotherapy using ex vivo-activated cytotoxic T lymph...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Immunotherapy
سال: 2012
ISSN: 1524-9557
DOI: 10.1097/cji.0b013e318243f213